The boosting of didanosine by allopurinol permits a halving of the didanosine dosage

AIDS

Volumn 16, Issue 16, 2002, Pages 2221-2223

  Boelaert, Johan R ^a   Dom, Geneviève M ^b   Huitema, Alwin D R ^c   Beijnen, Jos H ^c   Lange, Joep M A ^d  

^a General Hospital St Jan   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c SLOTERVAART HOSPITAL   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CD4 ANTIGEN; CHLOROQUINE; DIDANOSINE; EFAVIRENZ; HYDROXYUREA; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DRUG BLOOD LEVEL; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL;

ADULT; ALLOPURINOL; ANTI-HIV AGENTS; DIDANOSINE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; HYDROXYUREA; MALE; PILOT PROJECTS; RNA, VIRAL;

EID: 0037045007     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200211080-00016     Document Type: Article

References (9)

1. Lori F. Hydroxyurea and HIV: 5 Years later - From antiviral to immunomodulating effects. AIDS 1999, 13:1433-1442.
2. Liang D, Breaux K, Nornoo A, Phadungpojna S, Rodriguez-Barradas M, Bates TR. Pharmacokinetic interaction between didanosine (ddl) and allopurinol in healthy volunteers. In: 39th Interscience Conference on Antimicrobial Agents and Therapy. San Francisco, CA, USA, 26-29 September 1999, p. 25 [Abstract A662].
3. Liang D, Breaux K, Rodriguez-Barradas M, Bates TR. Allopurinol increases didanosine (ddl) absorption in HIV-infected patients. In: 41st Interscience Conference on Antimicrobial Agents and Therapy. Chicago, IL, USA, December 2001, p. 16 [Abstract A498].
4. Boelaert JR, Sperber K, Piette J. Chloroquine exerts an additive in vitro anti-HIV-1 effect, when associated with didanosine and hydroxyurea. AIDS Res Hum Retroviruses 1999, 114:1241-1247.
5. Savarino A, Gennero L, Chen HC, Malavasi F, Boelaert JR, Sperber K. Anti-HIV effects of chloroquine: Mechanisms of inhibition and spectrum of activity. AIDS 2001, 15:2221-2230.
6. Beijnen JH, Meenhorst PL, Rosing H, et al. Analysis of 2′,3′-dideoxyinosine (ddl) in plasma by isocratic high performance liquid chromatography with ultraviolet detection. J Drug Dev 1990, 3:127-133.
7. Moore RD, Keruly JC, Chaisson RE. Incidence of pancreatitis in HIV-1 infected patients receiving nucleoside reverse transcriptase inhibitor drugs. AIDS 2001, 15:617-620.
8. Barreiro P, Soriano V, Valencia E, Diaz B, Gonzales-Lahoz J. Low risk of pancreatitis in HIV-infected patients on hydroxyurea and didanosine. AIDS 2001, 15:2469-2470.
9. Martindale. The Complete Drug Reference, 32rd Ed. Parfitt K (editor). London: Pharmaceutical Press; 1999.